3 results
Primary objectiveTo evaluate and compare the single-dose pharmacokinetic of turoctocog alfa pegol from the pivotal process with turoctocog alfa pegol from the commercial process, each given as intravenous administrations of 50 U/kg to patients with…
The aim of this study is to assess the efficacy of oral administration of simvastatin plus rifaximin in patients with decompensated cirrhosis to halt the progression of the disease as assessed by prevention of the development of ACLF.
The main objective of this trial is to investigate the ability to visualize the exact location of left and right confluence of the bile ducts and thereby distinct between right and left hepatic ducts and the common hepatic duct using NIRF imaging.…